HAS-PFUE Colloquium "Evaluating health technologies together in Europe"

The entry into force of the European regulation on the assessment of health technologies marks the beginning of a new era. It establishes increased cooperation between the agencies of the European States in charge of these assessments, with the aim of facilitating the access to innovation with clinical benefit, in the interest of patients. How can this objective be met without departing from the quality, security and transparency requirements that any health technology assessment requires? What are the long-term success factors, such as in times of crisis?

This international and participatory symposium, organized as part of the French presidency of the Council of the European Union, aims to shed light on these essential public health issues.

Program

10:30 a.m. - Opening speeches

11 a.m. - Keynote

11:15 a.m. - Cooperation of hypertension agencies in Europe: from experience sharing to common assessments

Focus: Challenges and issues of the new European HVA regulation

Implementation of the European MV regulation

Contribution of European cooperation in MV

Patient involvement

Participation of the pharmaceutical industry

Questions answers

2 p.m. - The challenge of the method for European MV agencies

The work of the EUnetHTA 21 consortium

Challenges of health technology assessment methods

Focus on the evaluation of technologies using artificial intelligence

Discussion

3 p.m. - Innovation in the context of a health crisis: the role of European hypertension agencies

Perspective from health technology assessment agencies

Industry point of view

Round table

4 p.m. - Closing

*This event is not organized by the French Government. It is however authorized by the latter to use the emblem of the French Presidency of the Council of the European Union.